Top Markets
Coin of the day
Gubra A/S Gubra A/S

Gubra A/S

GUBRA
Rangering i aksjer #9438
Gubra A/S is a biotechnology firm engaged in two core activities: offering... Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.
Aksjekurs
$61.73
Sist synkronisert: 2026-08-28
Markedsverdi
$1.01B
Endring (1 dag)
-1.02%
Endring (1 år)
5.10%
Land
DK
Handel Gubra A/S (GUBRA)

Kategori

EPS for Gubra A/S (GUBRA)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Gubra A/S er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Gubra A/S fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -
US
$27.74 -
NL
$-5.29 -
AU
$-7.98 -
US
- -
CH